Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Page 1
Importance of reassessment to identify trajectories of chronic transition of clinical indicators in post-myocardial infarction management.
Yoshioka G, Tanaka A, Sonoda S, Kaneko T, Hongo H, Yokoi K, Natsuaki M, Node K. Yoshioka G, et al. Among authors: sonoda s. Cardiovasc Interv Ther. 2024 Apr 14. doi: 10.1007/s12928-024-01000-w. Online ahead of print. Cardiovasc Interv Ther. 2024. PMID: 38615302 Review.
We speculate that post-MI reassessment of key clinical indicators and the impact of their chronic transition patterns on long-term prognoses can improve the quality of post-MI risk stratification and help identify residual risk factors. ...
We speculate that post-MI reassessment of key clinical indicators and the impact of their chronic transition patterns on long-term pr …
Pulmonary Vein Intervention for Severe Pulmonary Vein Stenosis After Atrial Fibrillation Ablation　- A Retrospective Cohort Study.
Yokoi K, Katsuki T, Yamaguchi T, Otsubo T, Soga Y, Hiroshima K, Sonoda S, Node K. Yokoi K, et al. Among authors: sonoda s. Circ J. 2024 Mar 16. doi: 10.1253/circj.CJ-23-0892. Online ahead of print. Circ J. 2024. PMID: 38494711 Free article.
The objective of this study was to describe interventional treatments for PVS after AF ablation and long-term outcomes in Japanese patients.Methods and Results: This multicenter retrospective observational study enrolled 30 patients (26 [87%] male; median age 55 years) wit …
The objective of this study was to describe interventional treatments for PVS after AF ablation and long-term outcomes in Japanese pa …
Sex Differences in 5-Year Outcomes After Deferral of Revascularization Following Physiological Coronary Assessment.
Ishihara T, Kuramitsu S, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Yokoi H, Tanaka N, Mano T; J-CONFIRM Investigators. Ishihara T, et al. Among authors: sonoda s. Circ Rep. 2024 Jan 31;6(2):19-27. doi: 10.1253/circrep.CR-23-0100. eCollection 2024 Feb 9. Circ Rep. 2024. PMID: 38344391 Free PMC article.
Background: The relationship between sex differences and long-term outcomes after fractional flow reserve (FFR)- and instantaneous wave-free ratio (iFR)-guided deferral of revascularization has yet to be elucidated. Methods and Results: From the J-CONFIRM registry (long- …
Background: The relationship between sex differences and long-term outcomes after fractional flow reserve (FFR)- and instantaneous wa …
Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial.
Saito Y, Tanaka A, Imai T, Nakamura I, Kanda J, Matsuhisa M, Uehara H, Kario K, Kobayashi Y, Node K; PROTECT investigators. Saito Y, et al. Hypertens Res. 2024 Jan;47(1):168-176. doi: 10.1038/s41440-023-01494-6. Epub 2023 Nov 14. Hypertens Res. 2024. PMID: 37964067 Clinical Trial.
Although previous reports have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors have a blood pressure (BP) lowering effect, relevant long-term data is limited. This study aimed to evaluate the effect of the SGLT2 inhibitor ipragliflozin on BP, and associations …
Although previous reports have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors have a blood pressure (BP) lowering effect, rele …
Prognostic Impact of Renal Function on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization.
Itakura R, Kuramitsu S, Kikuchi J, Kawase Y, Mizukami T, Shinozaki T, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Yokoi H, Tanaka N, Matsuo H; J‐CONFIRM investigators. Itakura R, et al. Among authors: sonoda s. J Am Heart Assoc. 2023 Oct 17;12(20):e030886. doi: 10.1161/JAHA.123.030886. Epub 2023 Oct 7. J Am Heart Assoc. 2023. PMID: 37804198 Free PMC article.
However, few large-scale data are available regarding clinical outcomes after FFR-guided deferral of revascularization in patients with CKD. Methods and Results From the J-CONFIRM registry (Long-Term Outcomes of Japanese Patients With Deferral of Coronary Intervention Base …
However, few large-scale data are available regarding clinical outcomes after FFR-guided deferral of revascularization in patients with CKD. …
Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: Practical Application.
Sonoda S, Node K. Sonoda S, et al. Interv Cardiol Clin. 2023 Apr;12(2):167-175. doi: 10.1016/j.iccl.2022.12.001. Epub 2023 Jan 31. Interv Cardiol Clin. 2023. PMID: 36922058 Review.
All these are essential to maximize the results of revascularization while minimizing acute complications, ultimately leading to improved long-term clinical outcomes....
All these are essential to maximize the results of revascularization while minimizing acute complications, ultimately leading to improved lo …
Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions (update).
Sonoda S, Hibi K, Okura H, Fujii K, Node K, Kobayashi Y, Honye J. Sonoda S, et al. Cardiovasc Interv Ther. 2023 Jan;38(1):1-7. doi: 10.1007/s12928-022-00892-w. Epub 2022 Sep 19. Cardiovasc Interv Ther. 2023. PMID: 36117196 Review.
This should lead to further improvements of the procedures, which in turn will lead to improved short- and long-term prognosis. Then, high-quality PCI could be possible. This review summarizes the standard usage of IVUS in routine clinical practice and the use of IVUS in s …
This should lead to further improvements of the procedures, which in turn will lead to improved short- and long-term prognosis. Then, …
Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow Reserve.
Ueki Y, Kuramitsu S, Saigusa T, Senda K, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Sasaki Y, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Kanemura N, Sonoda S, Yokoi H, Tanaka N; J-CONFIRM Investigators. Ueki Y, et al. Among authors: sonoda s. Circ J. 2022 Aug 25;86(9):1329-1336. doi: 10.1253/circj.CJ-21-1024. Epub 2022 Mar 12. Circ J. 2022. PMID: 35283368 Free article.
BACKGROUND: Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization based on fractional flow reserve (FFR).Methods and Results: From the J-CONFIRM registry (long-term outcomes of Japanese patients with def …
BACKGROUND: Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization base …
Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve Assessment.
Shiono Y, Kuramitsu S, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Tanaka A, Yokoi H, Tanaka N; J-CONFIRM Registry Investigators. Shiono Y, et al. Among authors: sonoda s. JACC Cardiovasc Interv. 2022 Feb 28;15(4):427-439. doi: 10.1016/j.jcin.2021.11.020. JACC Cardiovasc Interv. 2022. PMID: 35210049 Free article.
BACKGROUND: Deferral of revascularization on the basis of FFR is generally considered to be safe, but after deferral, some patients have cardiovascular events over time. METHODS: From J-CONFIRM registry (Long-Term Outcomes of Japanese Patients With Deferral of Coronary Int …
BACKGROUND: Deferral of revascularization on the basis of FFR is generally considered to be safe, but after deferral, some patients have car …
Five-Year Outcomes After Fractional Flow Reserve-Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry.
Kuramitsu S, Matsuo H, Shinozaki T, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Yokoi H, Tanaka N; J-CONFIRM Investigators. Kuramitsu S, et al. Among authors: sonoda s. Circ Cardiovasc Interv. 2022 Feb;15(2):e011387. doi: 10.1161/CIRCINTERVENTIONS.121.011387. Epub 2022 Feb 8. Circ Cardiovasc Interv. 2022. PMID: 35130711
BACKGROUND: Little large-scale data is available about the long-term (beyond 3 years) clinical outcomes after fractional flow reserve (FFR)-based deferral of revascularization in clinical practice. ...Notably, cardiac death and target vessel-related myocardial infarction r …
BACKGROUND: Little large-scale data is available about the long-term (beyond 3 years) clinical outcomes after fractional flow reserve …
40 results